OKUR (OnKure Therapeutics) Pretax Margin %: % (As of Mar. 2026)


OKUR OnKure Therapeutics Inc OKUR
14 GF Score
Price $4.50
! 1 Warning Sign
View Full Analysis

What is OnKure Therapeutics Pretax Margin %?

OnKure Therapeutics OKUR +0.22% 14 Pretax Margin % is % as of Mar. 2026. GuruFocus rates OKUR with a GF Score™ of 14/100. The stock has 1 warning sign investors should review. Among 944 Biotechnology companies, OnKure Therapeutics ranks worse than 105932.1% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. OnKure Therapeutics's Pre-Tax Income for the three months ended in Mar. 2026 was $-15.16 Mil. OnKure Therapeutics's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, OnKure Therapeutics's pretax margin for the quarter that ended in Mar. 2026 was %.

The historical rank and industry rank for OnKure Therapeutics's Pretax Margin % or its related term are showing as below:


OKUR's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -90.5
* Ranked among companies with meaningful Pretax Margin % only.

OnKure Therapeutics  (NAS:OKUR) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

OnKure Therapeutics Pretax Margin % Related Terms

OnKure Therapeutics Pretax Margin % Historical Data

* Premium members only.

The historical data trend for OnKure Therapeutics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OnKure Therapeutics Pretax Margin % Chart

OnKure Therapeutics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Pretax Margin %
0.00 0.00 0.00 0.00

OnKure Therapeutics Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OKUR vs ANTX, PLX, KRRO: Pretax Margin % Comparison

For the Biotechnology subindustry, OnKure Therapeutics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OnKure Therapeutics Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OnKure Therapeutics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where OnKure Therapeutics's Pretax Margin % falls into.


OKUR
14GF Score
OnKure Therapeutics Inc OKUR
Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OnKure Therapeutics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

OnKure Therapeutics's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-59.517/0
= %

OnKure Therapeutics's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-15.157/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
OnKure Therapeutics (OKUR) has a Pretax Margin % of % as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on OnKure Therapeutics and its competitors. According to the industry distribution chart, OnKure Therapeutics ranks #999999 out of 944 companies in the Biotechnology industry.
Is OnKure Therapeutics' Pretax Margin % too high?
OnKure Therapeutics' current Pretax Margin % is %. Based on the distribution chart, OnKure Therapeutics ranks #999999 out of 944 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, OnKure Therapeutics has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does OnKure Therapeutics' Pretax Margin % compare to ANTX and PLX?
According to the Biotechnology industry distribution chart, OnKure Therapeutics ranks #999999 out of 944 companies for Pretax Margin %. This places OnKure Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on OnKure Therapeutics and its competitors. OnKure Therapeutics's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OnKure Therapeutics stock overvalued right now?
OnKure Therapeutics (OKUR) has a current Pretax Margin % of %. The current Pretax Margin % is %. OnKure Therapeutics' overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For OnKure Therapeutics (OKUR), the current Pretax Margin % is % as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OnKure Therapeutics Business Description

Address 6707 Winchester Circle, Suite 400, Boulder, CO, USA, 80301
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3K?. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
14GF Score

Get the complete analysis for OKUR

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.50
Price